On April 23, Sirio Pharma released its financial report for the first quarter of 2025. During the reporting period, the company recorded revenue of RMB 954 million (approximately USD 131.8 million), representing a year-on-year increase of 0.28%. Net profit reached RMB 68.64 million (approximately USD 9.48 million), showing a year-on-year growth of 8.90%. (Source: Company Announcement)
Sign Up to Receive China Updates Weekly Newsletter for FREE, HERE
Visit HPA-China’s Information Hub, HERE